- QMRO Home
- William Harvey Research Institute
- Centre for Translational Medicine & Therapeutics
- Bruton's tyrosine kinase inhibition attenuates disease progression by reducing renal immune cell invasion in mice with hemolytic-uremic syndrome
Browse
Administrators only